• Keefe, 72, was one of the first patients dosed with Sutent for GIST in April 2002.

    FORBES

  • Afinitor will share the kidney cancer market with three other new drugs, including Pfizer's Sutent.

    FORBES: Magazine Article

  • Pfizer says it is monitoring all its trials of Sutent and has not seen any problems.

    FORBES: Questions Swirl Around Avastin

  • Last week, Pfizer was denied its patent rights to its cancer drug, Sutent.

    FORBES: It's Time To Stop Outsourcing Pharma R&D To India

  • Sutent, a targeted cancer pill, could become a big drug if ongoing studies in breast cancer prove effective.

    FORBES: Pfizer's New Blockbuster Drug

  • Three years after the first patient got Sutent, the drug has been shown to help patients live longer.

    FORBES

  • Results are due for Sutent in breast cancer, where Avastin slowed the disease but did not prolong survival.

    FORBES: Can Cancer Cure Pfizer?

  • Rubin remains bullish on recently-approved drugs such as Sutent, used to treat gastrointestinal tumors, and Exubera, developed for diabetes.

    FORBES: Pfizer To Benefit From Recent Launches

  • Late yesterday, the drug giant recieved approval for Sutent, a new anticancer pill, for both stomach and kidney tumors.

    FORBES: Magazine Article

  • Andy Crabb, who has kidney cancer, has paid out thousands of pounds for Sutent over the past few months.

    BBC: Cancer patient wins drugs battle

  • In kidney cancer, Sutent shrank tumors by 40% in two midstage clinical trials.

    FORBES: Pfizer Takes Cancer By Storm

  • That was more than it was forecasting for Sutent, an innovative cancer pill, or Chantix, a first-of-its kind anti-smoking drug.

    FORBES: Pfizer Kills Exubera

  • It shows Sutent shrank tumors by a third or more in 14% of 51 patients who were available for evaluation.

    FORBES: Pfizer Takes Cancer By Storm

  • Eleven abstracts on Sutent will be presented at the annual meeting of the American Society for Clinical Oncology in May.

    FORBES: Pfizer's Tough Transition

  • Her decision to follow the guidance means the drug Sutent can be used as a first treatment for advanced kidney cancer.

    BBC: Kidney drugs no longer available

  • Here at the cancer meeting, data were presented on AG-13736, another pill that hits two of the five cancer proteins Sutent targets.

    FORBES

  • It took just three years to prove that Sutent benefited his patients.

    FORBES: Magazine Article

  • Early results are promising, and the second compound may lack Sutent's side effects, which include fatigue, an incredibly sensitive tongue and yellowed skin.

    FORBES

  • One piece of evidence is in the trials Demetri conducted of Sutent for gastrointestinal stromal tumors (GIST), a deadly disease but a tiny market.

    FORBES

  • Demetri of the Dana-Farber Cancer Institute, who codesigned trials of AP23573 after big successes with other fast-tracked pills, such as Gleevec and Pfizer's Sutent.

    FORBES: Mission Improbable

  • It has high hopes for its new kidney cancer drug Afinitor, which helps patients whose disease is resistant to Pfizer's kidney tumor drug Sutent.

    FORBES: Magazine Article

  • Pfizer 's ( PFE - news - people ) kidney cancer drug Sutent for short periods of time and then stopping.

    FORBES: Questions Swirl Around Avastin

  • Previous trials have shown Sutent extends life in patients with stomach cancer and shrinks kidney tumors--results that could put it on the market next year.

    FORBES

  • The competition is stiff, especially with promising breast cancer data expected from Pfizer 's (nyse: PFE - news - people ) Sutent.

    FORBES: Genentech's Wall Of Data

  • Pfizer has submitted Sutent, a cancer drug that Chief Executive Henry "Hank"McKinnellHenry "Hank" McKinnell has described as "revolutionary", to the U.S. Food and Drug Administration.

    FORBES: Magazine Article

  • Without Sutent, he says, he might have missed his two grandsons.

    FORBES: Pfizer Takes Cancer By Storm

  • Sutent has doubled the life expectancy of some patients in trials.

    BBC: NEWS | UK | England | Manchester | Friends fund Wilson's cancer drug

  • Yesterday, in an interview, Pfizer research chief John LaMattina predicted that Sutent would be the beginning of a big presence in oncology for the drug giant.

    FORBES: Magazine Article

  • Sutent made sense as a follow-up drug because it hit several defective proteins involved in cancer and, it was hoped, would get around the tumor cells' resistance.

    FORBES

  • In March, NICE ruled against the use of two drugs, Lapatinib and Sutent, that prolong the life of those with certain forms of breast and stomach cancer.

    WSJ: Of NICE and Men

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定